When is tumour removal surgery recommended for neuroendocrine tumours?

Neuroendocrine tumours can begin in organs such as the bowel, pancreas, stomach or lung. The team identifies the primary site, grade, hormone activity, size and spread before recommending an operation. Surgery may remove the primary tumour, nearby lymph nodes or a limited area of spread. In some cases, it is used even when all disease cannot be removed because reducing active tumour tissue may ease obstruction, bleeding, pain or hormone symptoms.

The operation may be open, keyhole or endoscopic, depending on the organ and tumour position. Medicines, radiotherapy, liver-directed procedures or other treatments may be combined with surgery. A specialist team weighs expected benefit against effects on digestion, hormone balance and organ function.

Ask which tests define the tumour’s grade, hormone activity and spread. Tell the team about flushing, diarrhoea, wheezing, low blood sugar, abdominal pain or episodes of dizziness, because these details can affect preparation. Review medicines and fasting instructions carefully. Discuss whether surgery is intended to remove disease, prevent a blockage, control hormones or obtain more tissue for diagnosis.

Arrange review for persistent abdominal pain, vomiting, bowel changes, unexplained weight loss, recurrent flushing, wheezing or a new lump. After surgery, seek urgent advice for fever, worsening pain, wound problems, repeated vomiting, severe diarrhoea, fainting or symptoms of high or low blood sugar. Call emergency services for collapse, severe breathing difficulty or chest pain.

Where did the tumour start and what is its grade? What is the operation meant to achieve? Could lymph nodes or liver deposits be treated at the same time? How will hormone symptoms and digestion be monitored around surgery?